# Gentamicin Open Tibia Study

> **NCT05157126** · PHASE4 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 890 (estimated)

## Conditions studied

- Fracture Open Tibia

## Interventions

- **DRUG:** Gentamicin
- **DRUG:** normal Saline

## Key facts

- **NCT ID:** NCT05157126
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2028-04
- **Final completion:** 2029-04
- **Target enrollment:** 890 (ESTIMATED)
- **Last updated:** 2025-04-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05157126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05157126, "Gentamicin Open Tibia Study". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05157126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*